Site içinde arama yapın | Mạng Xã Hội levelzone.net

SUHAS KANDE bir dosya eklendi Other
2025-09-18 09:37:59 -

Glioblastoma Treatment Market Overview, Growth Analysis, Trends and Forecast By 2029
"Executive Summary Glioblastoma Treatment Market: Share, Size & Strategic Insights The expected CAGR of global glioblastoma treatment market is tend to be around 9.30% in the forecast period of 2022 to 2029. The market was valued at USD 2.34 billion in 2021, and it would grow upto USD 4.77 billion by 2029. For an excellent outcome of Glioblastoma Treatment Market report,...

0 Yorumlar 0 hisse senetleri 531 Views

Please log in to like, share and comment!
SUHAS KANDE bir dosya eklendi Other
2025-09-24 14:42:19 -

Glioblastoma Treatment Market Overview, Growth Analysis, Trends and Forecast By 2029
"Executive Summary Glioblastoma Treatment Market: Share, Size & Strategic Insights Data Bridge Market Research analyses a growth rate in the global glioblastoma treatment market in the forecast period 2022-2029. The expected CAGR of global glioblastoma treatment market is tend to be around 9.30% in the forecast period of 2022 to 2029. For an excellent outcome of Glioblastoma Treatment...

0 Yorumlar 0 hisse senetleri 312 Views

Please log in to like, share and comment!
SUHAS KANDE bir dosya eklendi Other
2025-09-16 07:48:25 -

Ipilimumab Market Overview, Growth Analysis, Trends and Forecast By 2029
"Latest Insights on Executive Summary Ipilimumab Market Share and Size Data Bridge Market Research analyses that the ipilimumab? market was valued at USD 2.026 million in 2021 and is expected to reach USD 4.34 million by 2029, registering a CAGR of 10.0% during the forecast period of 2022 to 2029. Objectives of the Market research are kept in mind while preparing the reliable Ipilimumab...

0 Yorumlar 0 hisse senetleri 739 Views

Please log in to like, share and comment!
SUHAS KANDE bir dosya eklendi Other
2025-09-18 11:46:17 -

Lentiviral Vector Market Overview, Growth Analysis, Trends and Forecast By 2032
Lentiviral Vector Market: Enabling Breakthroughs in Gene Therapy During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 11.90%, primarily driven by the rising demand for gene and cell therapies, especially in the treatment of cancer and genetic disorders. The Lentiviral Vector Market is emerging as a critical enabler of the biotechnology and pharmaceutical...

0 Yorumlar 0 hisse senetleri 748 Views

Please log in to like, share and comment!